Is Boston Scientific Corporation overvalued?

Boston Scientific Corporation (BSX) looks undervalued — trading about 67% below its fair value.

Undervalued

Price

$44.23

Fair value

$73.91

Current P/E

22.8

Normal P/E

38.1

Market cap

$65.74B

Dividend yield

0.0%

Return on equity

11.9%

Sector

Healthcare

Fair value compares BSX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks